SE417206B - Forfarande for framstellning av foreningar med autibiotisk verkan - Google Patents

Forfarande for framstellning av foreningar med autibiotisk verkan

Info

Publication number
SE417206B
SE417206B SE7402469A SE7402469A SE417206B SE 417206 B SE417206 B SE 417206B SE 7402469 A SE7402469 A SE 7402469A SE 7402469 A SE7402469 A SE 7402469A SE 417206 B SE417206 B SE 417206B
Authority
SE
Sweden
Prior art keywords
autibiotic
societies
procedure
preparation
action
Prior art date
Application number
SE7402469A
Other languages
English (en)
Inventor
B G Christensen
R W Ratcliffe
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE417206B publication Critical patent/SE417206B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
SE7402469A 1973-03-13 1974-02-25 Forfarande for framstellning av foreningar med autibiotisk verkan SE417206B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34080273A 1973-03-13 1973-03-13
US39751673A 1973-09-17 1973-09-17
US43274074A 1974-01-17 1974-01-17

Publications (1)

Publication Number Publication Date
SE417206B true SE417206B (sv) 1981-03-02

Family

ID=27407422

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7402469A SE417206B (sv) 1973-03-13 1974-02-25 Forfarande for framstellning av foreningar med autibiotisk verkan

Country Status (9)

Country Link
JP (1) JPS5029592A (sv)
AR (1) AR214161A1 (sv)
CH (1) CH616938A5 (sv)
DE (1) DE2411856A1 (sv)
ES (1) ES424204A1 (sv)
FR (1) FR2221123B1 (sv)
GB (1) GB1458410A (sv)
NL (1) NL7402539A (sv)
SE (1) SE417206B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2361885A1 (fr) * 1975-09-03 1978-03-17 Smithkline Corp Analogues de la penicilline, leurs intermediaires et procedes pour leur obtention
GB1515241A (en) * 1976-01-27 1978-06-21 Beecham Group Ltd Beta-lactam antibiotics
FR2552764A1 (fr) * 1983-05-17 1985-04-05 Chinoin Gyogyszer Es Vegyeszet Derives cephalosporaniques et penicillaniques semi-synthetiques contenant du phosphore, procede de preparation de ces derives et compositions pharmaceutiques les contenant
JPH029786Y2 (sv) * 1986-12-02 1990-03-12
JP5418814B2 (ja) 2009-03-13 2014-02-19 山本光学株式会社 ゴーグル

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577408A (en) * 1968-10-15 1971-05-04 American Home Prod Tetrahydro-2-oxofuran penicillins
CA1024518A (en) * 1972-04-10 1978-01-17 Queen's University Azetidinones and their production and use

Also Published As

Publication number Publication date
GB1458410A (en) 1976-12-15
DE2411856A1 (de) 1974-09-19
FR2221123A1 (sv) 1974-10-11
ES424204A1 (es) 1976-10-16
AU6629874A (en) 1975-09-11
JPS5029592A (sv) 1975-03-25
CH616938A5 (en) 1980-04-30
AR214161A1 (es) 1979-05-15
FR2221123B1 (sv) 1977-01-28
NL7402539A (sv) 1974-09-17

Similar Documents

Publication Publication Date Title
SE417205B (sv) Forfarande for framstellning av foreningar med autibiotisk verkan
SE423631B (sv) Forfarande for framstellning av oxaalhyl-dialkylxantiner
SE405599B (sv) Forfarande for framstellning av pyridazinoner med terapeutisk verkan
SE7710599L (sv) Forfarande for framstellning av bensisoxazoler
BE790016A (fr) Preparation de polyphosphazenes
SE411212B (sv) Forfarande for framstellning av 3-halogen-cefalosporiner
SE399701B (sv) Forfarande for framstellning av hydroxyalkyldiamin
SE415255B (sv) Forfarande for framstellning av furoylettiksyra - derivat med hypolipidemisk verkan
NO146596C (no) Fremgangsmaate for fremstilling av 6-deoksytetracykliner
SE417601B (sv) Forfarande for framstellning av amidinokarbamider
NO790627L (no) Fremgangsmaate for fremstilling av hydroksyalkylxantiner
SE395892B (sv) Forfarande for framstellning av piperidyl-bensimidazoliner med terapeutisk verkan
SE394436B (sv) Forfarande for framstellning av 7-halogen-linkomyciner
NO843825L (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin
SE426582B (sv) Forfarande for framstellning av foreningar med kolesterolsenkande effekt
SE417206B (sv) Forfarande for framstellning av foreningar med autibiotisk verkan
SE408418B (sv) Forfarande for framstellning av 5-fluor-pyrimidiner
SE409994B (sv) Forfarande for framstellning av amidinokarbamider
SE411211B (sv) Forfarande for framstellning av 3-halogencefalosporiner
SE389108B (sv) Forfarande for framstellning av cyklopropylfenylpyrrolidinderivat med farmakologisk verkan
SE394429B (sv) Forfarande for framstellning av aminopyrrolderivat med terapeutisk verkan
SE380795B (sv) Forfarande for framstellning av tiokarbamider
SE394680B (sv) Forfarande for framstellning av cykliska fosfamidderivat
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE7713839L (sv) Forfarande for framstellning av indanderivat med terapeutisk verkan